Related Experiment Videos

The PROMISE-ACHD Score: Prediction of Perioperative Mortality and Major Morbidity in Adult Congenital Heart Disease

Mike Saji1, Teiji Akagi2, Satoshi Yazaki3

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan; Department of Cardiology, Sakakibara Heart Institute, Fuchu, Japan.

JACC. Advances
|July 6, 2026
PubMed

Insights

A new surgical risk model, PROMISE-ACHD, accurately predicts mortality and major complications in adults with complex congenital heart disease. This tool aids in individualized surgical decision-making for ACHD patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Informatics

Background:

  • Perioperative complications significantly impact prognosis and quality of life in adults with congenital heart disease (ACHD).
  • Existing risk models inadequately predict mortality and morbidity in complex ACHD cases.
  • There is a critical need for improved risk stratification tools in this patient population.

Purpose of the Study:

  • To develop and validate a surgical risk model for predicting perioperative mortality and major morbidity.
  • To create a practical tool for risk stratification in adults with moderate-to-great complexity ACHD undergoing surgery.
  • To enhance individualized surgical decision-making for complex ACHD patients.

Main Methods:

  • Analysis of a registry of 1,002 patients with moderate or great ACHD complexity undergoing open-heart surgery.
  • Identification of independent predictors for a composite endpoint of in-hospital mortality and major perioperative complications.
  • Validation of the derived point-based score (PROMISE-ACHD) using bootstrap resampling and temporal/center-based cohorts.

Main Results:

  • The PROMISE-ACHD score demonstrated superior discrimination (AUC: 0.724) compared to existing models.
  • The model showed improved reclassification and good calibration in the derivation cohort.
  • Validation cohorts confirmed preserved discrimination (AUC: 0.784 and 0.773) and acceptable calibration.

Conclusions:

  • The PROMISE-ACHD score is a validated, practical tool for predicting mortality and major complications in complex ACHD surgery.
  • It utilizes contemporary clinical and imaging variables for accurate risk stratification.
  • The score can inform individualized surgical decision-making for ACHD patients.
Abstract